(Q36887909)

16 August 2017

1 reference

title

Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force (English)

1 reference

16 August 2017

0 references

D H Miller

1

1 reference

16 August 2017

1 July 1996

1 reference

Multiple Sclerosis Journal

16 August 2017

1 reference

16 August 2017

1

1 reference

16 August 2017

6

1 reference

16 August 2017

335-338

1 reference

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Long‐term follow‐up of acute partial transverse myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Time series for modelling counts from a relapsing-remitting disease: application to modelling disease activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

In vivo visualization of myelin water in brain by magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

The longstanding MS lesion. A quantitative MRI and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100610

10.1177/135245859600100610

21 January 2018

Identifiers

DOI

1 reference

release_mer25e2mf5gtnb7kc4mse4xqju

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mer25e2mf5gtnb7kc4mse4xqju

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9345412

1 reference

PubMed ID

9345412